z-logo
Premium
Synthesis of 2‐amino‐1,5‐dihydro‐1‐(methyl‐ 13 C)‐4H‐imidazol‐4‐one‐5‐ 13 C (creatinine‐ 13 C 2 )
Author(s) -
Cohen A.,
Hertz H. H.,
Schaffer R.,
Welch M. M.,
White E.
Publication year - 1987
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.2580240514
Subject(s) - chemistry , sarcosine , cyanamide , yield (engineering) , medicinal chemistry , sublimation (psychology) , creatine , organic chemistry , stereochemistry , glycine , nuclear chemistry , amino acid , psychology , biochemistry , materials science , metallurgy , psychotherapist
2‐Amino‐1,5‐dihydro‐1‐(methyl‐ 13 c)‐4h‐imidazol‐4‐one‐5‐ 13 c (creatinine‐ 13 C 2 ) ( 8 ) is synthesized as follows. Glycine‐2‐ 13 c ( 1 ) is tosylated; the product ( 2 ) is treated with iodomethane‐ 13 C; and the resultant doubly‐labeled product ( 3 ) is detosylated to yield sarcosine‐ 13 C 2 ( 4 ). Creatine‐ 13 C 2 ( 7 ) is obtained by treating 4 with 2‐methylisothiourea monohydriodide ( 5 ) or cyanamide ( 6 ). Dehydration of 7 under vacuum sublimation conditions gives 8 .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom